These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 6508408)

  • 1. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.
    Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
    Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
    Cox NH; Aitchison TC; Sirel JM; MacKie RM
    Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with 998 cutaneous melanomas of the head and neck over 30 years.
    O'Brien CJ; Coates AS; Petersen-Schaefer K; Shannon K; Thompson JF; Milton GW; McCarthy WH
    Am J Surg; 1991 Oct; 162(4):310-4. PubMed ID: 1951880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.
    Balch CM; Soong S; Ross MI; Urist MM; Karakousis CP; Temple WJ; Mihm MC; Barnhill RL; Jewell WR; Wanebo HJ; Harrison R
    Ann Surg Oncol; 2000 Mar; 7(2):87-97. PubMed ID: 10761786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia.
    Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
    Ann Surg; 1982 Dec; 196(6):677-84. PubMed ID: 7149819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous malignant melanoma of the head and neck.
    Fisher SR
    Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in head and neck melanoma. Effect of lesion location.
    Wanebo HJ; Cooper PH; Young DV; Harpole DH; Kaiser DL
    Cancer; 1988 Aug; 62(4):831-7. PubMed ID: 3395962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
    Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
    J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma.
    Urist MM; Balch CM; Soong S; Shaw HM; Milton GW; Maddox WA
    Cancer; 1985 Mar; 55(6):1398-402. PubMed ID: 3971310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients.
    Drepper H; Köhler CO; Bastian B; Breuninger H; Bröcker EB; Göhl J; Groth W; Hermanek P; Hohenberger W; Lippold A
    Cancer; 1993 Aug; 72(3):741-9. PubMed ID: 8334626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
    Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
    Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
    Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
    JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous melanoma of the head and neck.
    Vreeburg GC; Schouwenburg PF; Hilgers FJ; de Kraker NW; Hart AA
    Eur J Surg Oncol; 1988 Apr; 14(2):165-70. PubMed ID: 3360158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical course of cutaneous melanoma of the head and neck, and the factors affecting patient survival].
    Tarkov SA; Mikhnin AE; Shelekhova KV; Frolova OS; Nefedov AO
    Vopr Onkol; 2013; 59(1):114-7. PubMed ID: 23814837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous melanoma of the head and neck.
    Loree TR; Spiro RH
    Am J Surg; 1989 Oct; 158(4):388-91. PubMed ID: 2802047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node status is the most important prognostic factor in patients with melanoma of the scalp.
    Cappello ZJ; Augenstein AC; Potts KL; McMasters KM; Bumpous JM
    Laryngoscope; 2013 Jun; 123(6):1411-5. PubMed ID: 23625541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?
    Fadaki N; Li R; Parrett B; Sanders G; Thummala S; Martineau L; Cardona-Huerta S; Miranda S; Cheng ST; Miller JR; Singer M; Cleaver JE; Kashani-Sabet M; Leong SP
    Ann Surg Oncol; 2013 Sep; 20(9):3089-97. PubMed ID: 23649930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
    Erman AB; Collar RM; Griffith KA; Lowe L; Sabel MS; Bichakjian CK; Wong SL; McLean SA; Rees RS; Johnson TM; Bradford CR
    Cancer; 2012 Feb; 118(4):1040-7. PubMed ID: 21773971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.